Skip to main content
Watch Insiders
RCKTHealthcare

Rocket Pharmaceuticals Inc (RCKT) Insider Trading

In the last 90 days, 4 Rocket Pharmaceuticals Inc (RCKT) insiders reported no open-market purchases and 7 sales totaling $432,467. Source: SEC Form 4 filings.

SEC-reported filing activity is provided for research purposes and is not investment advice.

90-day C-suite buyers
0
90-day purchase value
$0.00
Corporate buyers
0
Latest transaction
Sep 11, 2026

Executive filings

Open-market transaction history

Purchase and sale summaries are ordered by the latest reported transaction date.

Open-market insider purchase and sale transactions
DateInsider nameRoleTypeSharesPriceTotal value
Sep 11, 2026Martin WilsonGeneral CounselSale75,364$3.40$256,464
Aug 18, 2026Martin WilsonGeneral CounselSale631$3.38$2,133
Aug 18, 2026Gaurav ShahCEOSale2,293$3.38$7,753
Aug 13, 2026Gaurav ShahCEOSale2,837$3.38$9,592
Aug 13, 2026Martin WilsonGeneral CounselSale3,493$3.38$11,810
Aug 11, 2026Christopher James StevensChief Operating OfficerSale36,658$3.50$128,266
Aug 11, 2026Sarbani ChaudhuriSee RemarksSale4,701$3.50$16,449
May 21, 2026Gaurav ShahCEOSale55,684$3.09$171,841
May 19, 2026Gaurav ShahCEOSale2,409$3.01$7,261
May 19, 2026Martin WilsonGeneral CounselSale662$3.01$1,995
🔒 Create Free Insider Alerts — Join Watch Insiders

Common questions

RCKT insider trading FAQ

Are RCKT insiders buying or selling?
Over the last 90 days, RCKT insiders were net sellers, reporting $0.00 of open-market purchases and $432,467 of sales.
When was the last RCKT insider purchase?
No open-market insider purchase of Rocket Pharmaceuticals Inc stock was reported in the last 90 days.
Where does RCKT insider trading data come from?
Watch Insiders reads the SEC Form 4 filings that Rocket Pharmaceuticals Inc officers, directors, and 10% owners submit to EDGAR, and refreshes this page daily.